Results 41 to 50 of about 4,685 (255)

Remimazolam-Based Anesthesia in Patients with Heart Failure Due to Mitral Regurgitation and Low Left Ventricular Function: A Case Series

open access: yesMedicina, 2023
Background and Objectives: Remimazolam is a new ultrashort-acting benzodiazepine anesthetic. Remimazolam appears to be useful in patients with severe valvular disease because of its minimal cardiovascular impact.
Atsuhiro Kitaura   +4 more
doaj   +1 more source

A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation

open access: yesClinical and Translational Science, 2021
The clinical effects of remimazolam (an investigational, ultra‐short acting benzodiazepine being studied in procedural sedation) were measured using the Modified Observer’s Assessment of Awareness/Sedation Scale (MOAA/S).
Jie Zhou   +7 more
doaj   +1 more source

Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single-Center Retrospective Cohort Study. [PDF]

open access: yesDEN Open
ABSTRACT Objectives Remimazolam is a novel ultra–short‐acting benzodiazepine that may offer advantages over conventional sedatives in endoscopic procedures. Evidence for its use in pancreatobiliary endoscopic ultrasonography (EUS) is limited. We compared the efficacy and safety of remimazolam and midazolam in outpatient pancreatobiliary EUS.
Toyonaga H   +16 more
europepmc   +2 more sources

Remimazolam as an Alternative Induction Agent in Monitored Anesthesia Care: An Educational Module [PDF]

open access: yes, 2023
Background: Propofol is a favored intravenous anesthetic; however, studies have shown propofol to have an unstable hemodynamic profile. Currently, myocardial infarction, secondary to intraprocedural hypotension and myocardial ischemia, is the leading ...
Brown, Kizzanna   +2 more
core   +1 more source

Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test—A Case Report and Literature Review

open access: yesMedicina, 2023
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test.
Sangho Lee   +7 more
doaj   +1 more source

Remimazolam vs. propofol for general anaesthesia in elderly patients:a meta-analysis with trial sequential analysis [PDF]

open access: yes
BACKGROUND Elderly patients comprise an increasing proportion of patients undergoing surgery, and they require special attention due to age-related physiological changes.
da Costa, Mariana Gaya   +6 more
core   +3 more sources

Intraoperative responses of motor evoked potentials to the novel intravenous anesthetic remimazolam during spine surgery: a report of two cases

open access: yesJA Clinical Reports, 2020
Background Remimazolam is a novel short-acting benzodiazepine characterized by metabolism independent from organ function. We report intraoperative MEP responses of two patients who underwent spine surgery under general anesthesia using remimazolam. Case
Takashi Kondo   +6 more
doaj   +1 more source

Effect of the of remazolam toluenesulfonate and IPACK on postoperative rehabilitation and sedation in elderly patients undergoing knee arthroplasty [PDF]

open access: yes, 2022
Purpose: To investigate the effect of the combination of remazolam toluenesulfonate and infiltration between the popliteal artery and capsule of the knee (IPACK) on the rehabilitation and sedation of elderly patients undergoing knee arthroplasty. Methods:
Huang, Gang   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy